Huntsman Cancer Institute (HCI) has a robust and highly interactive Senior Leadership team comprised of eight individuals: HCI Executive Director: Mary Beckede, PhD Senior Director of Finance and Administration: Scott Lloyd, MBA, CPA Senior Director of Basic Science: Barbara Graves, PhD Senior Director of Early Translational Research: David Jones, PhD Senior Director of Clinical Research: Sunil Sharma, MD Senior Director of Community Oncology Research: Wallace Akerley, MD Senior Director of Prevention and Outreach: Randall Burt, MD Senior Director of Clinical Affairs: Sean Mulvihill, MD Huntsman Cancer Hospital (HCH) Executive Director: Ray Lynch, MBA, CPA The Senior Leadership is responsible for strategic planning, integration, financial management, and evaluation of all three areas of the HCI mission: research, clinical care, and education/outreach. In the research arena, members of the Senior Leadership oversee CCSG Programs, Shared Resources, and Support Services such as the Protocol Review and Monitoring System. They also provide leadership regarding data and safety monitoring as well as participation of minorities and children in clinical trials. HCI Senior Leadership forms the Director's Cabinet. The Cabinet meets weekly for one to two hours with an agenda and holds a two-to-three day off-site retreat in the winter each year, as well as a multi-day spring conference to review and finalize the next year's budget. In addition, each Senior Leader meets individually with Dr. Beckerle on a regulady scheduled weekly, bi-weekly, or monthly (minimum level) calendar, depending on particular needs. The Executive Director and Senior Directors of Finance and Administration, Basic Science, Eady Translational Research, Clinical Research, Community Oncology Research, and Prevention and Outreach are members of the Research Leadership Council, which leads the direction of the Cancer Center's research Programs and support services. Section 7.1 describes the key appointments, credentials, and responsibilities of the Executive Director and each Cabinet member, which are critical to achieve the strategic goals of HCI as an NCI-Designated Cancer Center. Though not directly involved in leading the CCSG efforts, the Senior Director of Clinical Affairs and HCH Executive Director support the goals of the CCSG by overseeing clinical operations and planning as well as facilitating integration of HCI's research and clinical care missions.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA042014-23S1
Application #
8533381
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-05-01
Budget End
2013-04-30
Support Year
23
Fiscal Year
2012
Total Cost
$3,410
Indirect Cost
$1,129
Name
University of Utah
Department
Type
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Warner, Echo L; Ding, Qian; Pappas, Lisa et al. (2017) Health Care Providers' Knowledge of HPV Vaccination, Barriers, and Strategies in a State With Low HPV Vaccine Receipt: Mixed-Methods Study. JMIR Cancer 3:e12
Affolter, Kajsa; Gligorich, Keith; Samadder, Niloy Jewel et al. (2017) Feasibility of Large-Scale Identification of Sessile Serrated Polyp Patients Using Electronic Records: A Utah Study. Dig Dis Sci 62:1455-1463
Fowler, Brynn; Samadder, N Jewel; Kepka, Deanna et al. (2017) Improvements in Colorectal Cancer Incidence Not Experienced by Nonmetropolitan Women: A Population-Based Study From Utah. J Rural Health :
Ou, Judy Y; Smits-Seemann, Rochelle R; Kaul, Sapna et al. (2017) Risk of hospitalization among survivors of childhood and adolescent acute lymphoblastic leukemia compared to siblings and a general population sample. Cancer Epidemiol 49:216-224
VanderLinden, Ryan T; Hemmis, Casey W; Yao, Tingting et al. (2017) Structure and energetics of pairwise interactions between proteasome subunits RPN2, RPN13, and ubiquitin clarify a substrate recruitment mechanism. J Biol Chem 292:9493-9504
Cohen, Adam L; Factor, Rachel E; Mooney, Kathi et al. (2017) POWERPIINC (PreOperative Window of Endocrine TheRapy Provides Information to Increase Compliance) trial: Changes in tumor proliferation index and quality of life with 7 days of preoperative tamoxifen. Breast 31:219-223
Gardiner, Jamie D; Abegglen, Lisa M; Huang, Xiaomeng et al. (2017) C/EBP?-1 promotes transformation and chemoresistance in Ewing sarcoma cells. Oncotarget 8:26013-26026
Ding, Yun; Fleming, Aaron M; Burrows, Cynthia J (2017) Sequencing the Mouse Genome for the Oxidatively Modified Base 8-Oxo-7,8-dihydroguanine by OG-Seq. J Am Chem Soc 139:2569-2572
Carleton, Julia B; Berrett, Kristofer C; Gertz, Jason (2017) Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor ?-Bound Enhancers. Cell Syst 5:333-344.e5
Lai, Run-Zhi; Han, Xue-Sheng; Dahlquist, Frederick W et al. (2017) Paradoxical enhancement of chemoreceptor detection sensitivity by a sensory adaptation enzyme. Proc Natl Acad Sci U S A 114:E7583-E7591

Showing the most recent 10 out of 1113 publications